205 related articles for article (PubMed ID: 34037478)
1. Molecular Mechanisms of Azole Resistance in Four Clinical
Shi H; Zhang Y; Zhang M; Chang W; Lou H
Microb Drug Resist; 2021 Dec; 27(12):1641-1651. PubMed ID: 34037478
[TBL] [Abstract][Full Text] [Related]
2.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
Liu JY; Shi C; Wang Y; Li WJ; Zhao Y; Xiang MJ
Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
[TBL] [Abstract][Full Text] [Related]
5. Loss of C-5 Sterol Desaturase Activity in
Luna-Tapia A; Butts A; Palmer GE
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
[TBL] [Abstract][Full Text] [Related]
6. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
8. Upc2-mediated mechanisms of azole resistance in
Li J; Aubry L; Brandalise D; Coste AT; Sanglard D; Lamoth F
Microbiol Spectr; 2024 Feb; 12(2):e0352623. PubMed ID: 38206035
[No Abstract] [Full Text] [Related]
9. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing.
Spettel K; Barousch W; Makristathis A; Zeller I; Nehr M; Selitsch B; Lackner M; Rath PM; Steinmann J; Willinger B
PLoS One; 2019; 14(1):e0210397. PubMed ID: 30629653
[TBL] [Abstract][Full Text] [Related]
10. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
11. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
14. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.
Wang H; Kong F; Sorrell TC; Wang B; McNicholas P; Pantarat N; Ellis D; Xiao M; Widmer F; Chen SC
BMC Microbiol; 2009 Aug; 9():167. PubMed ID: 19682357
[TBL] [Abstract][Full Text] [Related]
15. Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
Feng LJ; Wan Z; Wang XH; Li RY; Liu W
Chin Med J (Engl); 2010 Mar; 123(5):544-8. PubMed ID: 20367978
[TBL] [Abstract][Full Text] [Related]
16. A newly identified amino acid substitution T123I in the 14α-demethylase (Erg11p) of Candida albicans confers azole resistance.
Wu Y; Gao N; Li C; Gao J; Ying C
FEMS Yeast Res; 2017 May; 17(3):. PubMed ID: 28334124
[TBL] [Abstract][Full Text] [Related]
17. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
[TBL] [Abstract][Full Text] [Related]
18. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
Vale-Silva LA; Coste AT; Ischer F; Parker JE; Kelly SL; Pinto E; Sanglard D
Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt.
El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM
Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
